Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Yan Yi, Shenglei Ge
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

An Epigenetic Role of Mitochondria in Cancer
Yue Liu, Chao Chen, Xinye Wang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2518-2518
Open Access | Times Cited: 85
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 19
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity
M. Honer, Benjamin Ferman, Zach H. Gray, et al.
Genes & Development (2024) Vol. 38, Iss. 11-12, pp. 473-503
Open Access | Times Cited: 7
Role Of Epigenetic Drugs In Sensitizing Cancers To Anticancer Therapies: Emerging Trends And Clinical Advancements
Deepti Singh, Mohammad Afsar Khan, Hifzur R. Siddique
Epigenomics (2023) Vol. 15, Iss. 8, pp. 517-537
Closed Access | Times Cited: 15
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 15
Approaching the catalytic mechanism of protein lysine methyltransferases by biochemical and simulation techniques
Philipp Schnee, Jürgen Pleiss, Albert Jeltsch
Critical Reviews in Biochemistry and Molecular Biology (2024) Vol. 59, Iss. 1-2, pp. 20-68
Open Access | Times Cited: 5
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges
Sarah Gold, Ali Shilatifard
Journal of Clinical Investigation (2024) Vol. 134, Iss. 20
Open Access | Times Cited: 5
Discovery of the First-in-class DOT1L PROTAC Degrader
Hyerin Yim, Renhong Sun, Zhongli Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117595-117595
Closed Access
Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 20
Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy
Mo-Fan Huang, Yuanxin Wang, Yu‐Ting Chou, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 4
MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications
Joanna Szczepanek, Andrzej Tretyn
Biomolecules (2023) Vol. 13, Iss. 11, pp. 1590-1590
Open Access | Times Cited: 9
PolyAMiner-Bulk is a deep learning-based algorithm that decodes alternative polyadenylation dynamics from bulk RNA-seq data
Venkata S. Jonnakuti, Eric J. Wagner, Mirjana Maletić‐Savatić, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 2, pp. 100707-100707
Open Access | Times Cited: 3
Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted Therapy
Mo-Fan Huang, Yuanxin Wang, Yu‐Ting Chou, et al.
(2024)
Open Access | Times Cited: 3
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
The role of epigenetics in women’s reproductive health: the impact of environmental factors
Xinru Yu, Jiawei Xu, Bihan Song, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Epigenetic therapeutic strategies in pancreatic cancer
Arturo Orlacchio, Stephen Muzyka, Tamas A. Gonda
International review of cell and molecular biology (2024), pp. 1-40
Closed Access | Times Cited: 2
An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system
Liam Kealy, Jessica Runting, Daniel Thiele, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1915-1915
Open Access | Times Cited: 2
Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities
Rajita Vatapalli, Alex P. Rossi, Ho Man Chan, et al.
Epigenomics (2024), pp. 1-16
Open Access | Times Cited: 2
Diverse modes of regulating methyltransferase activity by histone ubiquitination
James K. Fields, Chad W. Hicks, Cynthia Wolberger
Current Opinion in Structural Biology (2023) Vol. 82, pp. 102649-102649
Open Access | Times Cited: 6
A Comprehensive Overview of Recent Advances in Epigenetics in Pediatric Acute Lymphoblastic Leukemia
Paulina Drożak, Łukasz Bryliński, Joanna Zawitkowska
Cancers (2022) Vol. 14, Iss. 21, pp. 5384-5384
Open Access | Times Cited: 9
Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies
Zsuzsanna Gaál
Biomolecules (2022) Vol. 13, Iss. 1, pp. 61-61
Open Access | Times Cited: 8
Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development
Jixia Li, Maggie L. Kalev‐Zylinska
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 4
Trending Drugs Combination to Target Leukemia associated Proteins/Genes: using Graph Neural Networks under the RAIN Protocol
Mahnaz Boush, Ali Akbar Kiaei, Hossein Mahboubi
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top